AI assistant
Sending…
Immuneering Corp — Director's Dealing 2022
Mar 23, 2022
32973_dirs_2022-03-23_f6352c4f-da6f-41f8-8b1b-bf13d8d5c30f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-03-23
Reporting Person: Hall Brett Matthew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-23 | Class A Common Stock | P | 1050 | $7.91 | Acquired | 330134 | Direct |
More from Immuneering Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Major Shareholding Notification
2026
Jan 22